Nuvation BioNUVB -4.91%33 Days Inventory is 207.56 as of Mar. 2026, which is 54% below its 10-year median of 447.95. GuruFocus rates NUVB with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Nuvation Bio ranks worse than 51.25% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Nuvation Bio's Average Total Inventories for the
three
months ended in Mar. 2026 was $13.6 Mil. Nuvation Bio's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $6.0 Mil.
Hence, Nuvation Bio's Days Inventory for the
three
months ended in Mar. 2026 was 207.56.
The historical rank and industry rank for Nuvation Bio's Days Inventory or its related term are showing as below:
NUVB'
s Days Inventory Range Over the Past 10 Years
Min: 185.51 Med: 447.95 Max: 447.95
Current: 185.51
During the past 6 years, Nuvation Bio's highest Days Inventory was 447.95. The lowest was 185.51. And the median was 447.95.
NUVB's Days Inventory is ranked worse than 51.25% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs NUVB: 185.51
Nuvation Bio's Days Inventory
increased
from Mar. 2025 (0.61) to Mar. 2026 (207.56).
It might indicate that Nuvation Bio's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nuvation Bio's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nuvation Bio's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.16.
Nuvation Bio (NYSE:NUVB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nuvation Bio's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nuvation Bio's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nuvation Bio Days Inventory Related Terms
Nuvation Bio Days Inventory Historical Data
* Premium members only.
The historical data trend for Nuvation Bio's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NUVB vs VRDN, STOK, ATAI: Days Inventory Comparison
For the Biotechnology subindustry, Nuvation Bio's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuvation Bio Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nuvation Bio's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nuvation Bio's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuvation Bio (NUVB) has a Days Inventory of 207.56 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nuvation Bio and its competitors. This is 54% below median its historical median of 447.95. Over the past decade, Nuvation Bio's Days Inventory has ranged from 185.51 to 447.95. According to the industry distribution chart, Nuvation Bio ranks #327 out of 638 companies in the Biotechnology industry, placing it in the top 51.3%.
Is Nuvation Bio's Days Inventory too high?
Nuvation Bio's current Days Inventory of 207.56 is 54% below median its 10-year median of 447.95. Over the past 10 years, this metric has ranged from a low of 185.51 to a high of 447.95. The Biotechnology industry median Days Inventory is 183.20. Nuvation Bio's value of 207.56 is 13.3% above this industry median. Based on the distribution chart, Nuvation Bio ranks #327 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nuvation Bio has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Nuvation Bio's Days Inventory compare to VRDN and STOK?
According to the Biotechnology industry distribution chart, Nuvation Bio ranks #327 out of 638 companies for Days Inventory. This places Nuvation Bio in the lower half of its industry. The industry median Days Inventory is 183.20. Nuvation Bio's value of 207.56 is 13.3% above this benchmark. Historically, Nuvation Bio's own Days Inventory has ranged from 185.51 to 447.95 over the past decade. While the company's 10-year median is 447.95 vs. the industry median of 183.20, Nuvation Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nuvation Bio's current Days Inventory of 207.56 is 13.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nuvation Bio and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nuvation Bio's current Days Inventory is 207.56, which is 54% below median its own 10-year median of 447.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvation Bio stock overvalued right now?
Nuvation Bio (NUVB) has a current Days Inventory of 207.56. The current Days Inventory is 207.56, which is 54% below median its 10-year median of 447.95 and 13.3% above the Biotechnology industry median of 183.20. Nuvation Bio's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nuvation Bio (NUVB), the current Days Inventory is 207.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
33GF Score
Get the complete analysis for NUVB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUVB has been successfully added to your 
